Year: 2016
Type: article
Abstract: considered for transplant in first remission.To our knowledge, there are no data on long-term outcome of NMP1 mutation positive patients transplanted after relapse.In conclusion, our single-institution experience supports the reported superior shortterm prognosis for patients with NPM1 mutated AML, but challenges the accepted notion of favorable long-term outcome in this population.Prospective clinical trials are needed to clarify long-term prognosis and optimal management of these patients.
Source: American Journal of Hematology
DOI: 10.1002/ajh.24604
Authors: Ibrahim Aldoss, Tracey Stiller, Joo Song, Monzr Al Malki, Haris Ali, Amandeep Salhotra, Ahmed Aribi, Samer Khaled, Popsie Gaytan, Joyce Murata‐Collins, Joycelynne Palmer, David Snyder, Margaret O'Donnell, Ryotaro Nakamura, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat
Institutions: City Of Hope National Medical Center, City of Hope
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2549678595